Brief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
12/10/2026 22:29
BRIEF-Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results Oct 12 (Reuters) - ImmuCell Corp ICCC.O:
IMMUCELL ANNOUNCES A 46% INCREASE IN PRODUCT SALES IN QUARTER THREE OF 2026, BASED ON PRELIMINARY, UNAUDITED SALES RESULTS
IMMUCELL CORP - Q3 2026 TOTAL SALES $8 MILLION, UP 46% FROM Q3 2025
IMMUCELL CORP - TO DISCONTINUE EARLY SALES REPORTING, WILL REPORT REVENUE AT QUARTERLY EVENTS
Source text: ID:nGNX6kSl4Y
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year